Drug profile · INN
insulin glargine [insulin glargine biosimilar 1]
INSULIN GLARGINE BS [LILLY]
insulin glargine [insulin glargine biosimilar 1] (INSULIN GLARGINE BS [LILLY]) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — insulin glargine [insulin glargine biosimilar 1]
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
insulin glargine [insulin glargine biosimilar 1] (INSULIN GLARGINE BS [LILLY]) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN insulin glargine [insulin glargine biosimilar 1]
Brand INSULIN GLARGINE BS [LILLY]
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is insulin glargine [insulin glargine biosimilar 1]?
insulin glargine [insulin glargine biosimilar 1] (INSULIN GLARGINE BS [LILLY]) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for insulin glargine [insulin glargine biosimilar 1]?
INSULIN GLARGINE BS [LILLY] is a marketed brand name for insulin glargine [insulin glargine biosimilar 1]. Check FDA Drugs@FDA for the current US label holder and prescribing information.